pindolol has been researched along with endralazine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bogers, WA; Holmes, DG; Huunan-Seppala, A; Wideroe, B; Wideroe, TE | 1 |
| Rawat, R; Seedat, YK | 1 |
| Bogers, WA; Meems, L | 1 |
2 trial(s) available for pindolol and endralazine
| Article | Year |
|---|---|
Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
Topics: Acetylation; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Genes; Humans; Hydralazine; Hydrazones; Hypertension; Male; Pindolol; Pyridazines | 1983 |
A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Clopamide; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Pyridazines; Time Factors | 1984 |
2 other study(ies) available for pindolol and endralazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.
Topics: Acetylation; Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Phenotype; Pindolol; Pyridazines; Time Factors; Vasodilator Agents | 1983 |